Latest Colossal News & Updates

See the latest news and media coverage for Colossal. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Colossal

Genetics and biosciences company focused on de-extinction

colossal.com
Headquarters
Dallas, United States
Founded year
2021
Company type
Private company
Number of employees
50–300

Last updated

Latest news about Colossal

In short: Colossal Biosciences advanced its de-extinction agenda by targeting the bluebuck, acquiring Viagen, and expanding its conservation funding to $100M.

Company announcements

  • Colossal

    Colossal wins gold at Edison Awards for blood cloning

    The non-invasive method, developed from dire wolf de-extinction, uses blood samples instead of tissue biopsies for efficiency and humanity.

  • Colossal

    Colossal builds new model for deep science

    Efforts generate transformative discoveries and durable commercial value simultaneously.

  • Colossal

    Colossal Biosciences targets bluebuck de-extinction

    The company adds the first antelope to its portfolio, using roan antelope as surrogate. It addresses antelope conservation crisis with genetic tools. Announcement made April 30, 2026.

  • Colossal

    Colossal develops cane toad–resistant super quolls

    They plan to use prime editing to change a single nucleotide and begin IVF trials within months, aiming for first edited joeys in about one year.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Colossal

Track Colossal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.